A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
Public ClinicalTrials.gov record NCT06013241. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps - The BiRCh Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of the study is to evaluate the efficacy of brensocatib at 10 and 40 milligrams (mg) once daily (QD) compared with placebo in improving clinical symptoms of CRSsNP.
Study identification
- NCT ID
- NCT06013241
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 288 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 30, 2023 (Actual)
- Primary completion
- Sep 30, 2025 (Actual)
- Completion
- Oct 30, 2025 (Actual)
- Last update posted
- Sep 30, 2026
2023 – 2025
United States locations
- U.S. sites
- 27
- U.S. states
- 14
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| USA034 | Tucson | Arizona | 85704 | — |
| USA002 | Roseville | California | 95661 | — |
| USA006 | Upland | California | 91786 | — |
| USA016 | Boca Raton | Florida | 33487 | — |
| USA019 | Hollywood | Florida | 33024 | — |
| USA001 | Miami | Florida | 33135 | — |
| USA009 | Tampa | Florida | 33613 | — |
| USA031 | Chicago | Illinois | 60611 | — |
| USA021 | Chicago | Illinois | 60612 | — |
| USA003 | New Albany | Indiana | 47150 | — |
| USA035 | Mandeville | Louisiana | 70471 | — |
| USA026 | Baltimore | Maryland | 21287 | — |
| USA011 | Columbia | Missouri | 65212 | — |
| USA024 | St Louis | Missouri | 63141 | — |
| USA033 | New York | New York | 10016 | — |
| USA028 | Tulsa | Oklahoma | 74132 | — |
| USA004 | Tulsa | Oklahoma | 74136 | — |
| USA015 | Hershey | Pennsylvania | 17033 | — |
| USA023 | Charleston | South Carolina | 29425 | — |
| USA022 | North Charleston | South Carolina | 29406 | — |
| USA025 | Dallas | Texas | 75231 | — |
| USA037 | Fredericksburg | Texas | 78624 | — |
| USA029 | Houston | Texas | 77022 | — |
| USA018 | Houston | Texas | 77030 | — |
| USA030 | San Antonio | Texas | 78258 | — |
| USA038 | Tomball | Texas | 77375 | — |
| USA005 | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 73 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06013241, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 30, 2026 · Synced Nov 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06013241 live on ClinicalTrials.gov.